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Increasing antibacterial resistance presents amajor challenge
in antibiotic discovery. One attractive target in Gram-negative
bacteria is the unique asymmetric outermembrane (OM),which
acts as a permeability barrier that protects the cell from external
stresses, such as the presence of antibiotics.We describe a novel
-hairpin macrocyclic peptide JB-95 with potent antimicrobial
activity against Escherichia coli. This peptide exhibits no cellu-
lar lytic activity, but electronmicroscopy and fluorescence stud-
ies reveal an ability to selectively disrupt the OM but not the
inner membrane of E. coli. The selective targeting of the OM
probably occurs through interactions of JB-95 with selected
-barrel OM proteins, including BamA and LptD as shown
by photolabeling experiments. Membrane proteomic studies
reveal rapid depletion of many -barrel OM proteins from
JB-95-treated E. coli, consistent with induction of a membrane
stress response and/or direct inhibition of the Bam folding
machine. The results suggest that lethal disruption of theOMby
JB-95 occurs through a novel mechanism of action at key inter-
action sites within clusters of -barrel proteins in the OM.
These findings opennew avenues for developing antibiotics that
specifically target -barrel proteins and the integrity of the
Gram-negative OM.
The discovery of novel antibiotics with new mechanisms of
action is an important goal in antibiotic research to combat
infections caused by multidrug-resistant bacteria, in particular
Gram-negative microorganisms with their unique asymmetric
outer membrane (OM)3 (1). Naturally occurring cationic host
defense peptides that formpart of the innate immunity inmany
organisms have recently attracted great interest in the search
for new clinically useful antibiotics (2). We explore here an
approach to antibiotic discovery based upon host defense
peptide-inspired macrocyclic peptidomimetics as a potential
source of antibiotics displaying target selectivity and potency
not seen with naturally occurring host defense peptides. In pre-
vious work (3), we described a family of macrocyclic -hairpin
peptidomimetics with potent and selective antimicrobial activ-
ity against Pseudomonas spp., which were shown to have a
novel mechanism of action targeting the -barrel outer mem-
brane protein LptD in Pseudomonas aeruginosa and inhibiting
its key lipopolysaccharide (LPS) transport function in OM bio-
genesis (4). We report here the discovery of a new conforma-
tionally constrained -hairpin peptidomimetic (called JB-95)
having potent antimicrobial activity against a panel of Gram-
positive and Gram-negative bacteria and, in particular, against
Escherichia coli. JB-95 shows minimal inhibitory concentra-
tions (MICs) of 0.25 g/ml against E. coli, including many
multidrug-resistant clinical strains. We report the solution
structure of JB-95 and investigations into its mechanism of
action against E. coli.
Experimental Procedures
Peptide Synthesis—Themethods for synthesis and character-
ization of all peptides have been described previously (5). JB-95
was of95% purity by analytical reverse phase HPLC (Waters
XBridgeTM (C18, 50  19 mm, 5 m, 135 Å) column with a
gradient of 5–90% MeCN in H2O (with 0.05% trifluoroacetic
acid). ESI-MS m/z 1970.1 ([MH], calc. 1970.0). See the
supplemental material for full 1H NMR assignments. For the
synthesis of the photoprobe PAL-95, Fmoc-Glu(biotiny-
PEG)-OH (Novabiochem) and Fmoc-L-Photo-Pro-OH were
used, along with other protected amino acids, following meth-
ods described earlier (3). PAL-95 purity was 95% by reverse
phase HPLC (C18Waters XBridge column using a linear gra-
dient of 10–60% MeCN in H2O). ESI-MS m/z 593.6
[M 4H]4, 791.4 [M 3H]3. Full details for the synthesis of
the fluorescent probe flJB-95 (MIC, 4 g/ml) are given in the
supplemental material.
Antibacterial Assays—MICs were determined in microtiter
plates in Mueller-Hinton-I (MH-I) medium using the broth
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microdilution method (6). The kinetics of cell death was mea-
sured under the same conditions, by taking aliquots of medium
and plating ontoMHagar plates with growth overnight at 37 °C
to determine colony-forming units.
NMR Studies—The solution structure of JB-95 was deter-
mined by 1H NMR spectroscopy. Distance restraints were
obtained from NOESY and ROESY spectra with a mixing time
of 250 ms. The structure calculations were performed by
restrained molecular dynamics in torsion angle space by apply-
ing the simulated annealing protocol implemented in the pro-
gram DYANA (7). See the supplemental material for a full
description of the results.
Macromolecular Biosynthesis Assays—Potential inhibitory
effects of JB-95 on macromolecular synthesis (protein, RNA,
DNA, cell wall) were monitored by incorporation of radioac-
tively labeled precursors in chemically defined medium in a
microplate format as described (8), using [3H]thymidine (80
Ci/mmol), L-[3H]leucine (108 Ci/mmol), and [3H]uridine (30
Ci/mmol) (from PerkinElmer Life Sciences) and N-[3H]acetyl-
glucosamine (30 Ci/mmol) and 2,6-[3H]diaminopimelic acid
(30 Ci/mmol) (from Biotrend Chemikalien).
Membrane Permeabilization Assay with SYTOX Green—
E. coliATCC25922was grown inMH-I at 37 °Cwith shaking to
anA600 of 0.2–0.3. The cells were collected and resuspended in
MH-I to A600 of 0.1. To this culture in a UV cuvette containing
a small magnetic stirrer bar and 0.002% of polyoxyethylene 80
(Tween 80) was added SYTOX Green dye (0.5 M), and the
fluorescence signal was monitored for 400 s. The test antibiotic
was added, and the fluorescence intensity was recorded during
1 h (PerkinElmer Life Sciences LS55 spectrometer; excitation at
488 nm, emission at 525 nm, and a slit width of 2.5 nm).
Fluorescence Microscopy—E. coli ATCC25922 was grown in
MH-II broth at 37 °C to anA600 of0.5–0.7. To an aliquot (200
l) was added JB-95 or polymyxin B (PMB), and the culture was
incubated at 30 °C for 1 h with shaking. Fluorescence dye
(FM4-64 (1 g/ml), SYTOX Green (0.5 M), DAPI (2 g/ml))
was added, and the broth was incubated at 0 °C for 10–15 min
(DAPI and SYTOX Green) or 45–60 min (FM4-64). The cells
were collected by centrifugation, washed withMH-II, and then
resuspended in MH-II (20 l). The samples were imaged on a
1.1% agarose patch using a Leica CLSM SP8 gSTED 3X micro-
scope, with laser excitation for DAPI (405 nm), SYTOX Green
(514 nm), or FM4-64 (520 nm) and a photomultiplier or hybrid
detector. Alternatively, to an aliquot of cell suspension in
MH-II was added the fluorescence probe flJB-95 (40 g/ml).
After 30 min at 30 °C, the cells were washed twice with MH-II
and examined as described above.
-Lactamase and -Galactosidase Assays—For periplasmic
-lactamase expression, E. coliATCC25922::pET3a was grown
in MH-II broth to an A600 of 0.3. The cells were collected,
washed, and resuspended in PBS supplemented with CaCl2 (1
mM) andMgCl2 (0.5mM) to anA600 of 0.2. To this suspension in
aUVcuvettewith 0.02%BSAwas added the chromogenic ceph-
alosporin CENTA (100M). After 1min, the test antibiotic was
added, and the A405 was monitored over time. The dose
response with antibiotic was studied in a 24-well plate format
using the cell suspension (848 l) and CENTA (100 M), incu-
bated at 37 °C, and shaken at 200 rpm for 1 h, before measur-
ing A405. For cytoplasmic -galactosidase expression, E. coli
XL1blue::pUC19 was grown in LB medium to an A600 of 0.3.
LacZ expression was induced with isopropyl 1-thio--D-ga-
lactopyranoside (100 g/ml), and incubation continued at
37 °C for 1 h to anA600 of0.6. The cellswere collected,washed
twice with fresh LBmedium, and then resuspended in PBS sup-
plemented with CaCl2 (1mM) andMgCl2 (0.5mM) to anA600 of
0.3. The cell suspension was distributed into a 24-well plate
with antibiotic, substrate (O-nitrophenyl--D-galactoside) was
added (0.5mM) and incubated at 37 °Cwith shaking for 1 h. The
cells were then removed by centrifugation, and the A420 was
measured.
Electron Microscopy (EM)—EM studies with E. coli
ATCC25922 treatedwith JB-95were performed usingmethods
described earlier (3).
Proteomics—E. coli ATCC25922 was grown in LB to end-ex-
ponential phase with JB-95 (5 g/ml), causing 50% growth
inhibition. Cells from treated and untreated cultures were har-
vested by centrifugation (three biological replicates each) and
lysed by French press, and membranes were isolated by differ-
ential centrifugation (30 min at 3005 g followed by 45 min at
100,000 g). Themembrane protein pellet was resuspended in
PBS, and 10 g of protein from treated and untreated cells
was analyzed by 12% SDS-PAGE with Coomassie staining
(Fig. 6A).
Proteins extracted from total membrane fractions of E. coli
grown in LBmediumwith or without JB-95were first separated
by 12% SDS-PAGE. After reduction and carbamidomethyla-
tion, the proteins were digested with trypsin (Promega, Madi-
son, WI), and the resulting peptides were separated by
RP-HPLC and analyzed by an LTQ-Orbitrap Velos mass spec-
trometer (Thermo Fisher Scientific) interfaced with a nano-
electrospray source. Mass spectra were further processed with
an in-house processing pipeline (9) that extracts fragment ion
mass spectra from Thermo RAW files using msconvert (Proteo-
Wizard, version 3.0.3831) and searches for matching peptides
in an E. coli K12 protein database (substrain MG1655,
NC_000913.3) containing 256 common contaminants (e.g.
human keratin, trypsin) with the search engine MS-GF (ver-
sion 9979), here using a 20-ppmmass tolerance window. Using
the decoy option of MS-GF, the list of peptide spectrum
matches was filtered to an estimated overall false discovery rate
of 0.1%, which amounted to a protein level false discovery rate
of about 1% when requiring two unambiguous peptides (class
1a or 3a based on a PeptideClassifier analysis (10) or three spec-
tra for protein identification in either condition). A total of 1740
proteins were identified overall. DESeq2 (11) (version 1.4.5)
was used to identify the most significantly regulated pro-
teins, here applying a q value threshold of 0.06 (Benjamini-
Hochberg adjusted p value indicating that roughly three false
positives are expected among the top 56 differentially regu-
lated proteins). Proteomics data associated with this paper
can be downloaded from the ProteomeXchange under acces-
sion number PXD002588.
Functional Analysis—For prediction of -barrel OM pro-
teins and subcellular localization, we relied on the publicly
available BOMP (12) and PSORTb version 3.0 (13)Web servers
(see Table 2), as described (14).
Mechanism of Action of a Peptidomimetic Antibiotic
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Quantitative PCR Analysis—E. coli ATCC25922 cells were
grown to end-exponential phase in the presence or absence of
JB-95. Cell harvest, RNA extraction, and cDNA synthesis were
as described previously (15). The expression of E. coli
ATCC25922 genes wcaI (EG11790), wzc (EG13568), murC
(EG10619), arnA (EG14091), ompF (EG10671), lptD
(EG11569), lamB (EG10528), and bamA (EG12676) was ana-
lyzed by quantitative RT-PCR (qRT-PCR) using Brilliant III
Ultra-Fast SYBR Green QPCR Master Mix (Agilent, Basel,
Switzerland) and an Mx3000P instrument (Agilent). Each PCR
was run in triplicate with three dilutions of cDNA (15, 7.5, and
3.75 ng) using 15 l of 2 Brilliant III Ultra-Fast SYBRGreen
QPCR Master Mix and 5 M individual primers in a total vol-
ume of 24 l. Melting curves were generated for verifying the
specificity of the amplification. The primers used are listed in
the supplemental material.
Photolabeling Experiments—Photolabeling experiments
with E. coliK12MG1655 and E. coliATCC25922 and the probe
PAL-95 (Fig. 1A) were performed using methods described in
detail elsewhere (3).
Results
Antimicrobial Activity—A screening effort uncovered the
backbone macrocyclic tetradecapeptide, called JB-95 (cyclo-
(Trp1-Arg2-Ile3-Arg4-Ile5-DArg6-Trp7-Lys8-Arg9-Leu10-
Arg11-Arg12-D-Pro13-Pro14); see Fig. 1A). JB-95 has good
antimicrobial activity against a panel of Gram-negative and
Gram-positive bacteria (Table 1). However, the antimicrobial
activity was considerably higher against E. coli (MIC 0.25
g/ml) and was maintained across a panel of E. coli clinical
strains showing resistance to a variety of knownantibiotics. The
enantiomer of JB-95 (ent-JB-95) shows 2–4-fold reduced anti-
microbial activity against all tested organisms. The kinetics of
E. coliATCC25922 cell killing in amicroplate format revealed a
bactericidal action over several hours at 2–8MIC, but not the
rapid killing caused by the cell lytic peptide protegrin I (PG-I)
(Fig. 1B).
Structural NMR Studies—The average solution structure of
JB-95 was determined by 1H NMR spectroscopy in aqueous
FIGURE 1. Structure and effects of JB-95 on E. coli. A, structure of JB-95. The fluorescence probe flJB-95 contains the residue B in place of Arg9 (dotted box);
The photoprobe PAL-95 contains residue Z in place of Arg9 and L-photoproline (dotted box) in place of L-Pro14. B, kinetics of killing of E. coli ATCC25922 in
microplate format by JB-95 andprotegrin-I in LB (control, no antibiotic).C, fluorescence increaseof E. coli cells treatedwithpolymyxin Bor JB-95 in thepresence
of SYTOX Green. Control with cells and SYTOX and no antibiotic is included. D, relative incorporation of 3H label from [1,6-3H]-N-acetylglucosamine () and
[2,6-3H]-diaminopimelic acid () into macromolecules in E. coli over 20 min at 37 °C with increasing concentrations of JB-95 (the vertical dotted line corre-
sponds to the MIC), showing the stimulated incorporation of label from N-acetylglucosamine. Error bars, S.E. of triplicate determinations.
TABLE 1
Antimicrobial activities
The MICs (g/ml) were measured using the broth microdilution assay. The six
non-ATCC E. coli strains are clinical isolates showing drug resistance to the antibi-
otics shown. nd, not determined.
Mechanism of Action of a Peptidomimetic Antibiotic
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buffer. A detailed analysis of two-dimensional 1H NOESY and
ROESY spectra revealed a dense network of cross-strand
nuclear Overhauser effects (NOEs), which, along with other
data, including amide chemical shift dispersions, 3JHNH cou-
pling constants, amide hydrogen/deuterium exchange rates,
and temperature coefficients (see the supplemental material),
clearly indicate a stable conformationally arrested -hairpin
structure within the JB-95 macrocycle. Structure calculations
were performed by restrained molecular dynamics in torsion
angle space with the program DYANA (7). A bundle of 20 con-
formations incurring the lowest DYANA target function were
selected, and a single representative structure is shown in Fig. 2.
All structures contain type II -turns within the template
(D-Pro13-L-Pro14) and at the tip of the loop (D-Arg6-L-Lys7),
with regular -strands connecting the two turn structures (16).
The NMR studies show that JB-95 adopts a stable -hairpin
conformation in aqueous solution.
Permeabilization of the OM—JB-95 showed no significant
lytic activity on human red blood cells at a concentration of 100
g/ml, which is well above the MIC. The permeabilizing effect
of JB-95 on E. coli ATCC25922 was investigated using the fluo-
rescent dye SYTOX Green. E. coli cells grown in MH-I broth
and then treated with SYTOX Green and JB-95 showed no
rapid increase in fluorescence over 1 h (Fig. 1C), whereas treat-
ment of cells with PMB leads within 20 min to a rapid charac-
teristic increase in green fluorescence, as both IM and OM are
permeabilized and the dye gains access to and binds nucleic
acids in the cytoplasm.
Macromolecular Synthesis Assays—We investigated the
influence of JB-95 on macromolecule biosynthesis in E. coli
ATCC25922 by monitoring the incorporation of radioactively
labeled precursors in chemically defined medium in a micro-
plate format (8). Labeling startswith exponentially growing cul-
tures at an A600 of 0.3, and the incorporation of label is per-
FIGURE 2. Solution structure of JB-95. A, the blue arrows indicate long range NOEs seen in two-dimensional 1H NMR NOESY and ROESY spectra. B, superim-
position and representationof thebackboneatomsof the final 20NMRstructures of JB-95. Side chains are omitted for clarity.Red, oxygenatoms;blue, nitrogen
atoms. The D-Pro-L-Pro template is shown to the right in pink. C, one typical average solution structure of JB-95.
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formed over a fixed period of only 20min to reveal direct effects
of the antibiotic, before secondary effects and cell death
become prominent. No significant inhibition by JB-95 was
observed of protein, RNA, or DNA biosynthesis, whereas con-
trol experiments with known antibiotics gave rise to the antic-
ipated inhibitory effects (not shown). Interestingly, JB-95
reproducibly caused a significant stimulation of radioactivity
incorporated from N-[3H]acetylglucosamine into macromole-
cules (Fig. 1D). In contrast, only a minor stimulation of tritium
incorporation was observed in labeling experiments using
[3H]diaminopimelic acid. The results are not consistent with a
direct inhibition of cell wall/membrane biosynthesis.
Microscopy Studies—The effects of JB-95 on E. coli cells
grown inMHwith concentrations of JB-95 causing 50% growth
inhibition for 1 h at 30 °Cwere analyzed using a high-resolution
stimulated emission depletion fluorescence microscope, with
staining of membranes by the membrane dye FM4-64 and of
nucleoids by DAPI and using SYTOXGreen to detect permea-
bilized cells (Fig. 3). The stained nucleoids were not influenced
significantly by JB-95, and apart from a small number of dead
cells, no significant staining (10% of cells) was observed by
SYTOXGreen. Relative to untreated cells, however, a large pro-
portion (50%) of cells treated with JB-95 were elongated and
contained unusual accumulations of membrane-like material
stained by FM4-64 (Fig. 3).
A derivative of JB-95 labeledwithAlexafluor-488 (called flJB-
95; see Fig. 1A) was prepared to study the uptake of the antibi-
otic by fluorescencemicroscopy. This derivative shows anMIC
of4g/ml and so retains a good antimicrobial activity against
E. coli. Cells were shaken with flJB-95 for 30 min in MH broth
and then examined using stimulated emission depletion
microscopy. The staining pattern (Fig. 3I) revealed that the
probewas concentrated into clusters or islands, consistent with
localized binding sites on the cell surface.
Evidence for a perturbation in membrane morphology was
revealed by transmission electron microscopy (TEM) of cells
grown in LB with JB-95 at concentrations causing 50% inhi-
bition of growth. In comparison with untreated controls, sec-
tions of treated E. coli cells appeared with a minimal periplas-
mic space and showed distinct ruptures in theOM,without any
apparent disturbance to the IM (Fig. 4,B andC).Many cells also
showed accumulations of unusual membrane-like material
between the IM and the OM (Fig. 4D). These microscopy stud-
ies indicate a dramatic effect of JB-95 on the outer cell mem-
brane. When JB-95-treated cells were examined by scanning
EM, the most notable feature compared with controls was the
appearance of knoblike structures over the surface ofmost cells,
which was not seen in the control (Fig. 4, E and F).
Susceptibility to Detergents and Antibiotics—E. coli cells
grownwith JB-95 at concentrations causing50% growth inhi-
bition were plated onto agar containing 0.5% SDS and 0.5 mM
EDTA or a selection of other antibiotics. The results revealed a
dramatic increase (104-fold) in the sensitivity of JB-95-
treated cells to growth on agar containing SDS/EDTA, com-
pared with untreated cells, consistent with a compromisedOM
permeability barrier allowing exposure of the IM to the lethal
actions of detergent (Fig. 5A). In agar disk diffusion assays, the
FIGURE 3. Fluorescence microscopy of E. coli cells. E. coli ATCC25922 cells
grown in MH-II without drug and stained with SYTOX Green, DAPI, and
FM-4-64 (A) and cells treated with either JB-95 (5 g/ml; B–E) or PMB (0.03
g/ml; F–H) for 1 h at 30 °C and labeled with fluorescent dye were analyzed
using a Leica CLSM SP8 gSTED microscope (scale bar, 4 m). A, control cells,
no drug; with JB-95; B, SYTOX Green staining (no signal visible); C, DAPI stain-
ing;D, FM4-64 staining; E, superimposition of B–D; with PMB; F, FM4-64 stain-
ing; G, SYTOX Green staining; H, superimposition of F and G; I, cells stained
with flJB-95 (see Fig. 1A) for 30 min in MH broth.
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treated cells also showed enhanced sensitivity to gentamycin,
chloramphenicol, nalidixic acid, and tetracycline.
-Lactamase and-GalactosidaseAssays—E. coli expressing
high levels of periplasmic -lactamase was grown in MH broth
to an A600 of 0.3. Cells were then collected and treated with
JB-95. Cell-free -lactamase activity was detected using the
chromophoric cephalosporin substrate CENTA (17) as a func-
tion of time and drug concentration, which revealed a rapid
release of the enzyme (Fig. 5,B andC). A similar releasewas also
observed from cells treated with PMB, which is known to per-
meabilize both the OM and IM of E. coli but (as expected) not
from cells exposed to ciprofloxacin. We also examined the
effect of JB-95 on E. coli expressing cytoplasmic -galactosid-
ase. These assays showed that JB-95-treated cells do not release
-galactosidase into the medium, whereas release is observed
when cells are treated with PMB or PG-I, consistent with the
known effects of PG-I and PMB on the permeability of both the
IM and OM (Fig. 5D).
Effects on the OM Proteome—The influence on the OM pro-
teome of E. coli ATCC25922 grown with JB-95 concentrations
causing 50% growth inhibition was investigated. Whole
membrane fractions isolated by differential centrifugation from
both treated and non-treated control cells were analyzed by
SDS-PAGE. The gels reveal a dramatic decrease in the relative
amounts of some membrane proteins compared with the
untreated control (Fig. 6A). To identifymembrane proteins dif-
ferentially expressed in the presence of JB-95, a semiquantita-
tive proteomic analysis was performed using in-gel digestion
and ESI-LC-MS/MS analyses. Data analysis was performed
using DESeq2 to identify the most significantly regulated pro-
teins between treated and untreated cells (each measured in
triplicate) (11, 14). The protein expression profiling experiment
identified a total of 1740 proteins. Applying a stringent selec-
tion of differentially expressed proteins (q 0.06), we identified
19 significantly up-regulated and 37 down-regulated proteins
(Fig. 6B) in JB-95-treated cells, as recorded in Table 2. We
observed that -barrel OM proteins and the larger group of
PSORTb OM proteins are significantly enriched among differ-
entially regulated proteins (p 1015, respectively).Most nota-
ble among the up-regulated are proteins involved in capsule
biosynthesis and export (Wzc, Wza, and Gmd), lipid A modifi-
cations (ArnA, ArnC, and EptA), OM stress responses (ClpX,
DegP, PhoQ, andRstB), and drug efflux (AcrD). Equally notable
among the significantly down-regulated proteins is the large
number of OM -barrel proteins, porins, and transporters
(Table 2). The level of the -barrel folding protein BamA was
not significantly changed by JB-95. However, suppressive
effects on BamA might be compensated by up-regulation as
part of an envelope stress response (E). To independently
assess the proteomics results, qRT-PCRanalysiswas performed
on independent biological replicate cultures, selectively target-
ing genes involved in capsule and murein biosynthesis (wcaI,
wzc, andmurC); aUDP-L-Ara4n-formyl transferase encoded by
arnA; and ompF, lptD, lamB, and bamA. These results revealed
genes that are strongly up-regulated (wcaI (10-fold),wzc (6-
fold), arnA (3-fold)), others that are down-regulated (ompF
(23-fold) and lamB (5-fold)), and somewhose levels are not
significantly changed by JB-95 (lptD (1.3-fold), bamA (1.3-
fold), and murC (1.6-fold)). A good correlation is seen
between the results at themRNA and protein levels formany of
these genes (Table 2), including bamA, whose level is not sig-
nificantly affected by JB-95.
Photolabeling Experiments—Photolabeling experiments were
carried out with the photoprobe PAL-95, which is identical to
JB-95 except for the replacement of L-Pro14 by the photoreac-
tive diazirine-containing L-photoproline (3), and of L-Arg9 by a
Glu(PEG2-biotin) (residue Z in Fig. 1A). PAL-95 retained a high
antimicrobial activity against E. coli (Table 1). Experiments
were performed with both the clinical isolate (ATCC25922)
and a genetically well characterized K12 strain. Results of pho-
tolabeling experiments in E. coliK12MG1655 are shown in Fig.
7. After photolabeling cells with PAL-95, theOMproteomewas
extracted and analyzed by two-dimensional gel electrophoresis.
Photolabeled, biotinylated proteinswere detected after blotting
to a membrane by chemiluminescence. Comparison of the
blots with Coomassie-stained two-dimensional gels from unla-
FIGURE 4. TEM (A–D) and scanning EM (E and F) studies of JB-95-treated
cells. E. coliATCC25922was grown in shake cultures in LBmediumwith JB-95
concentrations that cause50% growth inhibition. A, control, untreated (no
drug). B and C, cells grown with JB-95 (10 g/ml), showing breaks in the OM
(arrow). D, accumulations of membrane-like material in the periplasm of
JB-95-treated cells (arrow). The OM is also indicated. E, scanning EM of cells
without antibiotic and F, grownwith JB-95 (10g/ml) showing knoblike pro-
tuberances on the surface. Scale bars (white/black), 200 nm.
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beled OM proteome allowed identification of photolabeled
BamA and LptD on the basis of their unique and characteristic
positions in the two-dimensional gel, including characteristic
changes in the mobility of LptD in the gel before and after
reduction by DTT, as described earlier (18). Other photola-
beled proteins were detected around 67 and 40 kDa at positions
expected for BtuB and for LamB and FadL, respectively. The
most abundant OM proteins (OmpA/F) are not labeled by the
photoprobe. Photolabeling experiments with PAL-95 and
E. coli ATCC25922 gave similar results and also showed label-
ing of BamA, LptD, LamB, and FadL, but not BtuB (not shown).
These results show that JB-95 interacts with several -barrel
proteins in the OM of E. coli, including in both strains the
essential proteins LptD and BamA required for the biogenesis
of the OM.
Discussion
The macrocyclic -hairpin-shaped peptide JB-95 displays
antimicrobial activity against Gram-negative bacteria and
Staphylococcus aureus (Table 1). However, the activity against
E. coli is an order of magnitude higher, suggesting a selective
mechanism of action that merited further investigation.
JB-95 shows no cellular membranolytic activity, and the
kinetics of bacterial cell death reveals a clear difference
between the actions of PG-I and JB-95 (Fig. 1B). PG-I kills a
wide spectrum of Gram-positive and Gram-negative bacte-
FIGURE 5. Permeability effects caused by JB-95 on E. coli cells. A, E. coli grown in LB with JB-95 (5g/ml, causing 50% inhibition), adjusted to A600	 1 and
plated at increasing dilutions onto LB agar (left), or LB EDTA (0.5 mM) SDS (0.5%) (right). Cells are much more sensitive to SDS/EDTA after treatment with
JB-95. B andC,-lactamase assay. Cellswere treatedwith JB-95 (blue), polymyxin (red), or ciprofloxacin (brown) (untreated, green), and-lactamase releasewas
assayed with CENTA. B, kinetics of -lactamase release at the concentrations shown; C, dose-response curves relative to untreated cells. D, -galactosidase
assay. Cells treated with JB-95 do not release -galactosidase from the cytoplasm, whereas PMB and PG-I cause release. Dose-responses are shown, with the
green dotted line representing 100% release (lysed cells). A.U., absorbance units.
FIGURE 6. Proteomics studies. A, SDS-PAGE of the membrane extract
from treated () and untreated () E. coli ATCC25922, showing depletion
of some OM proteins in treated cells. B, differential protein expression
analysis. The log2 -fold change in the induced (I; with JB-95) versus unin-
duced (U; no JB-95) membrane proteome is shown against mean normal-
ized spectral count, analyzed using DESeq2. The most significantly differ-
entially expressed proteins are highlighted with red/green dots and are
listed in Table 2.
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ria within 20–30 min of cell contact at micromolar concen-
trations through a lytic mechanism of action (19). Further-
more, exposing cells to JB-95 does not lead to rapid
cytoplasmic uptake of SYTOX Green, in contrast to cyto-
plasmic staining seen after treatment with PG-I or PMB
(Figs. 1C and 3).
TEM studies provide evidence that JB-95-treated E. coli suf-
fer multiple50-nm breaches of the OM (Fig. 4) without visi-
ble effects on the IM. This differential effect on IM and OM
merits further attention and discussion. First, amphiphilic cat-
ionic antimicrobial peptides (CAMPs) with a membranolytic
mode of action, such as PG-I and PGLa, rapidly destabilize both
inner and outer membranes of E. coli at concentrations close to
the MIC (19–21). Permeabilization of both the OM and IM of
E. coli by the human antimicrobial peptide LL-37, with uptake
into the cytoplasm of SYTOX Green, has been documented by
real-time fluorescencemicroscopy (22). Indeed, many CAMPs,
including examples isolated from the innate immune systems of
various organisms as well as others of purely synthetic origin,
physically impair membrane bilayers (23–25). Several models
have been described to explain such activity, including forma-
tion of porelike structures and micellization of the membrane
TABLE 2
Differential membrane protein analysis
Shown are semiquantitative changes in 56 E. coliATCC25922 proteins that showed significant differential expression after JB-95 addition (I) compared with untreated cells
(U). The log2(I/U) -fold change in expression is shown (DESeq analysis q value 0.06). PSORTb-predictedOMproteins are highly enriched among differentially expressed
proteins (p  1015) and, except for the product of wza, are all down-regulated. Wza does not have a -barrel topology but rather a transmembrane domain of eight
-helices (61).
Class Locus IDa Localizationb
BOMP
predictionc Descriptiona Gene name
Log2 -fold changeI versus Ud
Energy production and conversion EG10095 Cytoplasmic L-Aspartate ammonia-lyase aspA 2.3
EG10232 CM DMSO reductase subunit A dmsA 3.2
EG10233 Unknown DMSO reductase subunit B dmsB 2.9
EG10330 CM Fumarate reductase flavoprotein subunit frdA 2.2
EG10331 CM Fumarate reductase iron-sulfur protein subunit frdB 1.9
EG10393 CM Anaerobic glycerol-3-phosphate dehydrogenase glpC 3.0
EG10701 Cytoplasmic Formate C-acetyltransferase; pyruvate formate-lyase pflB 1.4
EG11227 Periplasmic Formate dehydrogenase-N fdnG 2.3
EG11801 CM Hydrogenase-2 large subunit hybC 2.6
EG13006 CM Hydrogenase-2 small subunit hybO 2.4
EG13844 CM S- and N-oxide reductase, A subunit ynfF 3.9
Amino acid metabolism and transport EG10674 Periplasmic Oligopeptide-binding protein oppA 2.7
EG11005 Cytoplasmic Tryptophanase tnaA 1.6
EG10386 Periplasmic Glutamine-binding protein glnH 2.5
Nucleotide metabolism and transport EG12130 Cytoplasmic DnaK-like chaperone Hsc66 hscA 3.4
Carbohydrate metabolism and transport EG10283 Cytoplasmic Fructose-1,6-bisphosphatase fbp 2.9
EG10528 OM 4 Maltoporin, maltose high-affinity uptake system lamB 3.0
EG10560 Cytoplasmic Maltodextrin phosphorylase malP 2.5
Coenzyme metabolism EG10432 Cytoplasmic Glutamate-1-semialdehyde aminomutase hemL 2.3
Lipid metabolism EG10280 OM 5 Fatty acid transport protein fadL 2.3
Cell wall, membrane, envelope biogenesis EG10669 OM 1 Outer membrane protein A ompA 2.0
EG10670 OM 5 Outer membrane porin C ompC 2.7
EG10671 OM 5 Outer membrane porin F ompF 2.7
EG10738 OM 4 Outer membrane phospholipase A pldA 3.2
EG11035 OM 3 Outer membrane channel for nucleosides tsx 2.5
EG11124 OM 4 Outer membrane protein W ompW 3.0
EG11569 OM 1 LPS assembly complex LptD/E lptD 3.2
EG11787 Cytoplasmic Fucose biosynthesis; GDP-D-mannose 4,6-dehydratase gmd 3.5
EG11790 Cytoplasmic Putative colanic acid biosynthesis glycosyl transferase wcaI 3.2
EG12135 OM 5 Outer membrane protein X ompX 1.8
EG12513 OM 1 Assembly module for autotransporter export tamA 4.1
EG13492 OM 5 MltA-interacting protein mipA 3.1
EG13566 OM 2 Colanic acid export channel lipoprotein wza 3.5
EG13568 CM Tyrosine protein kinase; colanic acid production wzc 4.3
EG14090 CM Undecaprenyl phosphate-aminoarabinose synthase arnC 1.9
EG14091 Cytoplasmic UDP-glucuronate dehydrogenase arnA 3.1
Cell motility EG10321 Extracellular Flagellin, structural gene, H-antigen fliC 3.0
Post translational modifications EG10159 Cytoplasmic ATPase subunit of ClpXP protease clpX 2.0
EG10463 Periplasmic Periplasmic, membrane-associated serine endoprotease degP 2.1
Inorganic ion transport and metabolism EG10014 CM Aminoglycoside efflux pump; RND-type transporter acrD 3.7
EG10126 OM 3 Vitamin B12 outer membrane receptor btuB 4.1
EG10286 OM 1 OM ferric citrate receptor fecA 4.9
EG10302 OM 4 OM transporter for ferrichrome-iron fhuA 3.3
EG10514 CM Potassium-translocating ATPase, B subunit kdpB 3.8
EG12525 CM Magnesium transporter, ATP-dependent mgtA 4.5
EG13774 OM 1 Putative TonB-dependent OM receptor yncD 3.6
EG10260 Cytoplasmic Isochorismatase, aryl carrier protein (ArCP) entB 3.6
Signal transduction EG10732 CM Histidine protein kinase sensor protein phoQ 2.4
EG11233 CM Sensory histidine kinase of RstAB two-component system rstB 3.1
Intracellular trafficking and secretion EG11009 OM 0 OM factor (OMF) of tripartite efflux pumps tolC 2.3
EG12686 OM Antigen 43, phase-variable bipartite OM protein flu 2.5
Others EG10988 CM Aspartate, maltose chemoreceptor, methyl-accepting tar 3.2
EG11613 CM Lipid A phosphoethanolamine transferase eptA 1.8
EG12257 Unknown Oxidase involved in cellulose production bcsC 3.9
EG13693 Unknown DUF535 family protein, function unknown ybjX 4.5
EG13929 Unknown DUF1471 family periplasmic tridomain protein ydgH 4.0
a Gene number and nomenclature according to Ecogene version 3.0.
b Localization identified as described under “Experimental Procedures.” CM, cytoplasmic membrane.
c BOMP identified as described under “Experimental Procedures” (0	 did not find the protein to be an integral OM protein, but there were integral OM homologs; 1	 least
reliable prediction; 5	most reliable prediction).
d Log2 -fold change of protein expression, comparing induced cells (I, with JB-95) and uninduced (U, no drug).
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bilayer (26–28), although there is increasing evidence that
some CAMPs have alternative mechanisms of action, not
directly related to damage of the cytoplasmic membrane
(29–32).
The antibiotic PMB permeabilizes the OM before targeting
and disrupting the cytoplasmicmembrane in E. coli (33, 34). As
a result, PMB causes release into the medium of not only
periplasmic -lactamase but also cytoplasmic -galactosidase
(35, 36), as confirmed in our studies (Fig. 5). Earlier electrical
measurements with reconstituted planar bilayers suggested an
initial electrostatic interaction of PMB with the LPS outer leaf-
let, followed by formation of transient membrane lesions of
about 3 nm in diameter (37, 38). The lesions allow PMB and
other small molecules and ions to permeate the OM in both
directions (self-promoted uptake) (39) but appear to be quite
different in size and nature from the lesions induced by JB-95
(Fig. 4). Althoughwe observe complete release into themedium
of periplasmic -lactamase after treatment of cells with JB-95,
almost no release occurs of-galactosidase from the cytoplasm,
in contrast to observations made with PMB (Fig. 5). Moreover,
the damage to the OM caused by JB-95 accounts for the greatly
enhanced sensitivity of JB-95-treated cells to SDS/EDTA on
agar (Fig. 5A).
The integrity of the OM in Gram-negative bacteria is essen-
tial for survival and is monitored by several transcriptional sig-
naling systems, which can initiate damage repair responses.
One of these is the E stress response, which is activated by a
dual signal comprising incorrectly folded OM proteins and by
off-pathway intermediates in LPS transport and assembly in the
periplasm (40, 41). In response to these signals, E stimulates
the transcription of many genes, including all of the machinery
required for the transport and assembly of LPS and OM pro-
teins into the OM (42–44). However, E also induces expres-
sion of small regulatory RNAs, MicA and RydB, which act to
inhibit synthesis of several -barrel OM proteins (45, 46). The
Rcs phosphorelay is another signaling system inGram-negative
bacteria, which is induced by OM and cell wall damage and
controls the expression of genes involved in motility, extracel-
lular polysaccharide and biofilm formation, virulence, and
periplasmic quality control (47). Rcs regulates production of
capsular polysaccharide (colanic acid) and extracellular
polysaccharide, which help stabilize the OM and combat
envelope stress (48). Last, the PhoPQ two-component regu-
latory system in Gram-negative bacteria is important for
bacterial survival in host tissues and senses CAMPs and
induces responses that regulate the protein and lipid content
of the IM and OM (49, 50). In particular, PhoPQ-induced
modifications occur to the lipid A segment of LPS before
transport to the cell surface, such as the addition of cationic
moieties, including 4-amino-4-deoxyarabinose, that reduce
the net negative charge of the LPS and contribute to bacterial
resistance to CAMPs and PMB (51).
This background is helpful in understanding the response of
E. coli to JB-95. Thus, the stimulated incorporation of radiola-
beled N-acetylglucosamine into macromolecules (Fig. 1D) is
probably due to a stimulation of capsular polysaccharide pro-
duction. The appearance in scanning EM pictures of knoblike
structures over the surface of cells treatedwith JB-95 (Fig. 4F) is
reminiscent of previously reported surface-exposed poly-
GlcNAc (52). The dimensions of the knobs appear quite differ-
ent from the surface blebs that have been observed upon inhi-
bition ofE inE. coli (53) or themembrane protusions typical of
PMB-treated cells (54, 55). Moreover, the results of proteomic
and qRT-PCR studies show up-regulation triggered by JB-95 of
key proteins involved in capsular polysaccharide biosynthesis
and excretion (Wza, Wzc, and Wcal) (Table 2). The unusual
accumulations of membrane-like material observed by fluores-
cence and TEM (Figs. 3D and 4D) might be explained by a
build-up of intermediates in capsular polysaccharide or LPS
biosynthesis, linked to a C55-undecaprenoid lipid carrier (44,
56). The lipid-bilayer accumulations appear approximately 3
times thicker than a membrane phospholipid bilayer (compare
FIGURE 7. Photolabeling experiment with PAL-95. A, Western blot with
chemiluminescence detection of biotinylated proteins. OM proteins from
E. coli cells photolabeledwith PAL-95 (Fig. 1A) were separated by two-dimen-
sional electrophoresis and blotted to a PVDF membrane, and biotinylated
proteins were detected by chemiluminescence. The unique positions of
labeled BamA (95 kDa) and LptD (98 and130 kDa) in the two-dimensional
gels allow unambiguous identification of these labeled proteins in the blots.
LptD (oxidized) appears at 130 kDa, and LptD (reduced) appears at 98
kDa. B, Coomassie-stained two-dimensional gel of the OMproteins extracted
from E. coli.
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OM; Fig. 4D, arrows). Moreover, because down-regulation of
LptDwas observed here in the proteomic studies, impaired LPS
transport to the cell surface should be expected, which typically
leads to dramatic membrane ultrastructural changes (57–59).
Mutations in the inner membrane LPS and phospholipid flip-
pase MsbA have also been shown to cause inner membrane
reduplications and invaginations due to inhibition of lipid
export (60).
The proteomic studies reveal that many -barrel OM pro-
teins are down-regulated in JB-95-treated cells (Fig. 6 andTable
2). These results can be at least partly explained by a E-depen-
dent response acting through the small regulatory RNA MicA
and/or RydB, which have been shown to inhibit the synthesis of
many -barrel OM proteins in E. coli (45, 46) (Table 2). Inter-
estingly, the essential OM LPS translocase LptD was signifi-
cantly depleted in the proteomics study (Table 2), although by
qRT-PCR only a minor change was seen. In contrast, the regu-
lation of the essential -barrel folding machine BamA was
largely unaffected by JB-95 in both the proteomic andqRT-PCR
assays. Because BamA is known to be essential for the correct
folding and insertion of most -barrel proteins into the OM,
including LptD (42), an alternative explanation for the deple-
tion of many -barrel OM proteins may be that JB-95 inhibits
the function of BamA. The OM protein Wza, which is up-reg-
ulated by JB-95 (Table 2), has a transmembrane domain of eight
-helices (61) that is not dependent on BamA for insertion into
the OM (62). Other significant JB-95-induced proteomic
changes are increased levels of proteins active in maintenance
of the periplasm (DegP and ClpX) (63) and modifications to
lipid A through the PhoP/Q response (PhoQ, ArnA, ArnC, and
EptA) (51).
High-resolution fluorescence microscopy of E. coli cells
exposed to the fluorescently labeled form of JB-95 (flJB-95)
shows the peptide concentrated in a punctated pattern (Fig. 3H)
in the OM rather than binding uniformly over the cell surface.
Early EM and recent fluorescence labeling studies have shown
that many OM proteins in E. coli associate into islands or
patches in the OM (64–67). The labeling patterns seen with
flJB-95 suggest that the peptide is associating with OM protein
patches. This conclusion is supported by the photolabeling
studies, which show that JB-95 interacts with several -barrel
OM proteins (Fig. 7), interactions that might mediate the dis-
ruptive effects on the OM. For example, membrane thinning
caused by contact of lipid groupswithmembrane-bound-bar-
rel proteins might provide sensitive sites where OM disruption
mediated by JB-95 could occur (68). Alternatively, some of the
photolabeled -barrel OMproteins, including BamA and LptD
in two different E. coli strains, expose -strands by transient
opening of the -barrel to form lateral gates during transport,
folding, or translocation of substrate molecules across the
membrane (69–75) and might be vulnerable to interactions
with peptidomimetics having folded -hairpin structures.
These proposals might be testable in future work using recon-
stituted -barrel proteins in vitro. Finally, optimization of both
the antimicrobial and drug-like properties of molecules like
JB-95 could have important implications for the development
of a new class of antibiotics specifically targeting the Gram-
negative OM.
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Supporting Information 
A Peptidomimetic Antibiotic Targets Outer Membrane Proteins and Disrupts Selectively 
the Outer Membrane in Escherichia coli 
 
1. Peptide synthesis.   
2. NMR studies of the solution conformation of JB-95 
3. qPCR primers 
 
1. Peptide synthesis.   
Synthesis of the fluorescence probe flJB-95. 
The following synthetic route to the fluorescently labelled flJB-95 was followed: 
 
The cyclic peptide precursor was prepared by solid-phase assembly of a linear peptide 
precursor followed by macrocyclization in solution, using methods described earlier (1). 
Standard Fmoc-protected amino acids and Fmoc-Glu(PEG-N3)-OH were used for solid-
phase peptide synthesis. 
To the cyclic peptide (1.37 mg) in PBS (700 µL) was added BTTAA (2-[4-{(bis[(1-tert-
butyl-1H-1,2,3-triazol-4-yl)methyl]amino)methyl}-1H-1,2,3-triazol-1-yl]acetic acid(2)) 
(0.82 mg), sodium ascorbate (0.1 M, 30 µL), AlexaFluor-488 alkyne (0.25 mg, Molecular 
Probes, Inc.) in DMSO (100 µL) and CuSO4 (0.1 M, 30 µL). After 1 h another aliquot of 
sodium ascorbate (0.1 M, 30 µL) and CuSO4 (0.1 M, 30 µL) was added and stirred for 
another 1 h. The reaction was quenched by addition of water (1 mL) containing 0.1% 
TFA. The product was purified by reversed phase HPLC on an Agilent Eclipse XDB-C18 
semi-preparative column employing a MeCN/H2O gradient with 0.1% TFA. Yield 0.6 mg 
of an orange powder, 95% purity by reverse phase HPLC. Retention time = 9.55 min 
(Grace VYDAC® 218TP54, C18 column, 5 µm, 4.6x250 mm, flow 1 ml/min, gradient 
20-60% MeCN/H2O +0.1% TFA over 6 column volumes. High resolution ES-MS: m/z 
679.58826 (M+4H+), calc. mass 679.58786. 
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2. NMR Studies of the Solution Conformation of JB-95 
1H NMR measurements were performed either in H2O/D2O (9:1) or pure D2O at pH 5.6 
and pH 3. Spectra were acquired on a Bruker AV-600 spectrometer at 300 K. 1D and 2D 
TOCSY 1H NMR spectra were also recorded at various temperatures (280 K, 290 K, 310 
K and 320 K) for determination of the amide temperature coefficients. Water suppression 
was performed by presaturation. 1H-NMR assignments (given below) were made using 
2D DQF-COSY, TOCSY, NOESY and ROESY spectra. All spectra were referenced on 
internal trimethylsilyl propanoic acid (TSP). 
1H Chemical shifts of JB-95 in 90% H2O/10%D2O, pH 5, 300 K. 
 NH H-C(α) H-C(β) Others 
Trp1 7.87 4.88 3.31, 3.31 H(δ1) 7.36; H(ε3) 7.74; H(ζ2) 7.52; H(ζ3) 7.13; 
H(η2) 7.27; NH(ε1) 10.24 
Arg2 8.75 4.96 1.72,1.80 CH2(γ) 1.51, 1.64; CH2(δ) 3.13, 3.16; NH(ε) 7.22; 
NH2(η) -, - 
Ile3 8.65 4.50 1.77 CH2(γ1) 1.03, 1.31; CH3(γ2) 0.83; CH3(δ1) 0.80  
Arg4 8.56 5.04 1.60, 1.77 CH2(γ) 1.39, 1.46; CH2(δ) 3.15, 3.15; NH(ε) 7.16; 
NH2(η) -, - 
Ile5 8.37 4.17 1.68 CH2(γ1) 1.03, 1.38; CH3(γ2) 0.83; CH3(δ1) 0.80 
DArg6 8.81 3.99 1.38, 1.52 CH2(γ) 0.40, 1.07; CH2(δ) 2.85, 2.85; NH(ε) 6.78; 
NH2(η) -, - 
Trp7 8.93 4.90 3.10, 3.61 H(δ1) 7.27; H(ε3) 7.68; H(ζ2) 7.51; H(ζ3) 7.13; 
H(η2) 7.26; NH(ε1) 10.15 
Lys8 8.14 4.52 1.85, 1.85 CH2(γ) 1.38, 1.46; CH2(δ) 1.71, 1.71; CH2(ε) 3.01, 
3.01; CH3(ζ) - 
Arg9 8.59 4.94 1.75, 1.75 CH2(γ) 1.47, 1.65; CH2(δ) 3.16, 3.16; NH(ε) 7.29; 
NH2(η) -, - 
Leu10 8.87 4.72 1.55, 1.61 CH(γ) 1.54; CH3(δ) 0.88, 0.88 
Arg11 8.63 4.93 1.76, 1.87 CH2(γ) 1.52, 1.66; CH2(δ) 3.18, 3.18; NH(ε) 7.23; 
NH2(η) -, - 
Arg12 8.74 4.90 1.73, 1.92 CH2(γ) 1.62, 1.64; CH2(δ) 3.17, 3.25; NH(ε) 7.23; 
NH2(η) -, - 
Dpro13 - 4.71 1.90, 2.28 CH2(γ) 2.02, 2.14; CH2(δ) 3.50, 3.87 
Pro14  4.35 1.42, 1.95 CH2(γ) 0.85, 1.65; CH2(δ) 3.55, 3.64 
3JHNα coupling constants were determined from 1D spectra or from 2D NOESY spectra 
by inverse Fourier transformation of in-phase multiplets. [13C,1H]-HSQC spectra at 
natural abundance were recorded in pure D2O. Chemical shift deviations (CSDs) from 
statistical random coil values (Δδ=δobs-δcoil) for Hα, Cα and Cβ resonances were 
measured. In peptide segments of three or more consecutive residues with predominantly 
β-sheet conformations, positive Hα and Cβ CSDs (downfield shifts) in the range of  > 0.1 
ppm and  > 0.5 ppm are expected, whereas negative Cα CSDs  < 0.5 ppm are expected. 
The opposite trends apply to α-helical regions. 3JHNα values are correlated with the 
backbone torsion angle φ via the Karplus relation and should be  < 6 Hz in α-helices and 
> 8 Hz in β-sheets. Amide proton temperature coefficients  (-ΔδNH/T, ppb/K) are typically 
smaller than -4 to -5 ppb/K for amide protons that are shielded from solvent and/or are 
 3 
involved in intramolecular hydrogen bond formation. Relative H/D exchange rates of 
amide protons are slowed when the NH is involved in intramolecular hydrogen bonding 
or otherwise shielded form solvent accessibility. 
Cα and Cβ 13C-chemical shifts for JB-95, 3JHNα (Hz) values, amide temperature 
coefficients (− Δδ/T (ppb/K)) and amide NH relative H/D exchange rates (+ slow, ++ 
medium, +++ fast) in 90% H2O/10% D2O, pH  5,  300 K. 
 C(α) C(β) 3JHNα (Hz)  − Δδ/T (ppb/K) rel. NH kexch 
Trp1 56.62 31.05 8.6 1.7 + 
Arg2 55.48 31.46 8.6 7.7 +++ 
Ile3 59.81 41.71 9.4 3 + 
Arg4 55.22 32.0 9.1 6.7 ++ 
Ile5 60.4 39.30 9.5 2.1 + 
D-Arg6 58.02 28.96 4.4 7.6 +++ 
Trp7 56.58 29.8 9.3 9 +++ 
Lys8 56.03 34.63 8.7 3 ++ 
Arg9 55.45 31.57 9.1 7.1 +++ 
Leu10 54.28 45.1 9.0 2.9 + 
Arg11 55.52 31.91 8.6 6.9 +++ 
Arg12 52.98 32.08 nd 2.4 + 
D-pro13 61.42 30.73    
Pro14 63.68 32.17    
 
JB-95 appeared as a single species in solution, with trans peptide bonds. For example, a 
strong Hα-Hδ NOE was observed between Arg12-DPro13. The pattern of CSD values 
indicates a regular β-hairpin conformation with two extended β-strands between residues 
1-5 and 8-12 characterized by positive ΔδHα, positive ΔδCβ and negative ΔδCα values. 
The strands are separated by a turn characterized by negative ΔδHα, negative ΔδCβ and 
positive ΔδCα values at DArg6 and opposite CSD values at Trp7. These data are 
consistent with the formation of a type II’ β-turn. 3JNHαCΗ coupling constants show large 
values >8 Hz except for residue 6 in the turn region, which is clear evidence for 
predominantly extended backbone conformations. Furthermore, H/D exchange 
experiments show slowly exchanging amide protons at Trp1, Ile3, Ile5, Lys8, Leu10 and 
Arg12. These residues are expected to occupy hydrogen-bonding positions in a regular β-
hairpin register, due to intra-molecular hydrogen-bonding. The H/D exchange results 
correlate very well with the low NH temperature coefficients seen for these residues with 
values of < 4 ppb/K. The hydrogen bonds identified in these measurements were used as 
distance restraints in the calculation of the NMR-based structures. 
Distance restraints were obtained from NOESY and ROESY spectra with a mixing time 
of 250 ms. The structure calculations were performed by restrained molecular dynamics 
in torsion angle space by applying the simulated annealing protocol implemented in the 
program DYANA (3). Starting from 100 randomized conformations a bundle of 20 
conformations is selected, which incur the lowest DYANA target energy function. Well-
ordered average solution structures could be determined based on numerous inter-strand 
NOEs in aqueous solution, which reveal a high population of β-hairpin conformations. 
 4 
Characteristic backbone NOE connectivities of the β-hairpin fold could be observed in 
the NOESY spectrum between HN protons of Trp1-Arg12, Ile3-Leu10 and Ile5-Lys8. 
The calculated solution NMR structures converge to a narrow range of backbone 
conformations with an average rmsd to the mean structure of 0.9 Å. As assumed based on 
the CSD pattern in the tip region, a type II’ β-turn was found with characteristic Hα-HN 
and HN-HN NOEs between DArg6-Lys8 and Trp7-Lys8, respectively. 
Statistics for the final 20 NMR structures calculated for JB-95 calculated using DYANA 
are given below. 
 statisitics for JB-95 
Number of NOE upper-distance limits 
 
Intraresidue 
Sequential 
Medium- and long-range 
150 
 
80 
37 
33 
Residual target function value (Å2) 0.93 ± 0.18 
Mean rmsd values (Å) 
All backbone atoms 
All heavy atoms 
 
1.32 ± 0.80 
2.83 ± 1.01 
Residual NOE violations 
Number > 0.2  Å  
Maximum (Å) 
 
10 
0.34 
 
3. qPCR primers 
A list of primers used for qPCR analyses is given below. 
Oligonucleotides used for qPCR.  
Primer name Sequence (5' - 3') 
wcaI _F TTCGCGTTCGATGATGAATA 
wcaI _R TTCACCAATATTGCCGGAGT 
wzc _F GATGTCGAGTCTGGTCAGCA 
wzc _R CAGCACACCCACGATAGAAA 
murC _F ATGGTTTCCAGCATCTACGC 
murC _R GTATCCATGTGGTCGGCTTC 
arnA _F CCGCCATTAAACACGGTAAT 
arnA _R CGACCAGACGGTGAATTTCT 
ompF _F AGGCTTTGGTATCGTTGGTG 
ompF _R AGCCGCTGGTGTTTGTAAAT 
lptD _F TGACAGTTCACGTCGTTGGT 
lptD _R GAAACGGTGGCATTGAAGTT 
lamB _F TGGTGGTTCTTCCTCTTTCG 
lamB _R GAATAACCAGCCGTCTTTCG 
bamA _F CCCGTTTCAACATCGACTCT 
bamA _R GGTCACTTTGGTGCCGTTAT 
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